IndraLab

Statements


Prx-I inhibits CACNA1A. 1 / 1
| 1

reach
"The BI-TK and GCV treatment system exhibited a sustainable anti-tumor growth activity and induced apoptosis in bladder cancer tissues by inhibition of Prx-I through the NF-kappaB pathway."